Mckesson experts to discuss personalized medicine, advanced molecular
diagnostics and new payment models at 2011 world healthcare congress
Newton, mass.--(business wire)--mckesson will have a strong presence at this year’s world health care congress (whcc) in washington, d.c. on april 4-6, 2011 as the company’s experts will participate in and moderate key panels, as well as host a special event. during these venues at whcc, mckesson experts will share their perspectives on the most pressing issues and solutions in this age of reform – from personalized medicine and advanced molecular diagnostics – to innovative payment and care delivery initiatives addressing episodes of care, bundled payment and accountable care organizations (acos). leading mckesson’s thought leadership initiatives at whcc will be dr. emad rizk, mckesson health solutions president, who will join other healthcare leaders on a keynote panel titled “the era of personalized medicine.” dr. rizk will discuss using advanced molecular diagnostics to personalize care and drive improved patient outcomes. rizk’s co-presenters include joseph jimenez, ceo, novartis ag, francis s. collins, m.d., ph.d, director, national institutes of health, and harvey v. fineberg, m.d., ph.d, president, institute of medicine. in other whcc forums, dr. rizk will be addressing change management for payers, aligning payers and providers to address healthcare’s most pressing issues, and the critical success factors for new care and payment delivery models such as acos. dr. rizk has been recognized for the last two years as one of the 50 most powerful physician executives (modern physician) and as one of the top 100 most powerful people in healthcare (modern healthcare). “personalized medicine and new payment and care delivery models hold enormous promise and are beginning to approach the tipping point for changing the way healthcare works,” said rizk. “this year’s world health care congress provides an excellent opportunity for the industry to come together to discuss these critical issues and the change management initiatives needed to capitalize on them.” douglas moeller, m.d., mckesson health solutions medical director, will also be speaking at the event. he will be moderating the emerging trend forum on “personalized medicine and integrating genomics into plan design.” dr. moeller will lead a prestigious panel in a discussion on identification of high-risk patients, intervention strategies and advances in cataloging and analysis of treatments. he will be joined by mara g. aspinall, m.b.a, ceo, on-q-ity, inc, sharon levine, m.d., associate executive medical director, the permanente medical group; lee n. newcomer, m.d., m.h.a, senior vice president, oncology, genetics and women’s health, unitedhealthcare, and rebecca sutphen, m.d., facmg, president and chief medical officer, informed medical decisions. in his other whcc activities, dr. moeller will be discussing the importance of having a comprehensive vision and solution for care episode management—from managing “front-end” episode initiation to managing “back-end” claims transaction management, to analytics that drive improvements in clinical and financial outcomes. joining doctors rizk and moeller at whcc will be matthew zubiller, vice president, advanced diagnostics management at mckesson, who will all be on hand to discuss innovative mckesson solutions for managing the explosive growth of molecular and genetic diagnostics using evidence-based decision support. mr. zubiller, an industry expert on the $6.2 billion molecular diagnostics market, speaks around the country on the importance of aligning providers, payers, labs, and patients together into a networked marketplace for advanced diagnostics to ensure the best outcomes, at the right costs, over time. about mckesson mckesson corporation, currently ranked 14th on the fortune 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. over the course of its 178-year history, mckesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payers; hospital and retail pharmacy automation; and services for manufacturers and payers designed to improve outcomes for patients. for more information, visit http://www.mckesson.com.
